Skip to main content
GLOBUS MEDICAL INC logo

GLOBUS MEDICAL INC — Investor Relations & Filings

Ticker · GMED ISIN · US3795772082 LEI · 5299003M2P4CIK0RF205 US Manufacturing
Open in API
Filings indexed 753 across all filing types
Latest filing 2026-06-04 Declaration of Voting R…
Country US United States of America
Listing US GMED

About GLOBUS MEDICAL INC

https://www.globusmedical.com/

Globus Medical, Inc. is a medical device company that develops solutions for patients with musculoskeletal disorders. The company designs, manufactures, and distributes a comprehensive portfolio of products to improve clinical outcomes and advance patient care. Its offerings are organized into two categories: Musculoskeletal Solutions and Enabling Technologies. The Musculoskeletal Solutions portfolio includes a wide range of implants, instruments, and regenerative biologics for spine, trauma, and orthopedic procedures. The Enabling Technologies division features the Excelsius™ ecosystem, an advanced suite of robotics and navigation platforms designed to enhance surgical accuracy, efficiency, and safety. Globus Medical collaborates with surgeons and healthcare professionals to create procedurally integrated solutions that address unmet clinical needs and provides extensive surgeon education and training programs.

Recent filings

Filing Released Lang Actions
8-K
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is a Form 8-K “Current Report” primarily reporting the final voting tallies at the 2026 Annual Meeting of Stockholders (Item 5.07) and related board/plan amendments approvals. It provides detailed vote counts on director elections, plan amendment, auditor ratification, and executive compensation. This matches a Declaration of Voting Results filing rather than a full report or proxy materials.
2026-06-04 English
SD
Regulatory Filings Classification · 87% confidence The document is a U.S. SEC Form SD (“Specialized Disclosure Report”) containing the Company’s Conflict Minerals disclosure under Rule 13p-1. It is a mandatory regulatory filing rather than a complete financial report, presentation, management discussion, or proxy/annual report. It doesn’t fit any specialized category (e.g., earnings release, ESG report, interim report) and is best classified as a general regulatory submission. Therefore it falls under Regulatory Filings (RNS).
2026-05-27 English
10-Q - GLOBUS MEDICAL INC (0001237831) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-07 English
SCHEDULE 13G/A - GLOBUS MEDICAL INC (0001237831) (Subject)
Major Shareholding Notification
2026-03-26 English
8-K - GLOBUS MEDICAL INC (0001237831) (Filer)
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is the resignation of a board member, John A. DeFord, Ph.D., from the Board of Directors. This is explicitly described under Item 5.02, which relates to departure and election of directors or officers. There is no financial data or report attached, only a press release about the resignation. Therefore, this document is best classified as Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2026-03-23 English
4 - GLOBUS MEDICAL INC (0001237831) (Filer)
Director's Dealing
2026-02-27 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.